News
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) just released its latest quarterly results and things are looking bullish. Revenues of US$24m beat estimates by a substantial 228% margin. Unfortunately, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback